SCHEMBL926201

SCHEMBL926201

CC(C)(C)c1ccc(S(=O)(=O)N2c3ccccc3C[C@H]2C(=O)NCCc2ccccc2Oc2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.44
MMP8 P22894 4/20 0.40
MMP3 P08254 2/20 0.40
RORC P51449 1/20 0.40
PTGER3 P43115 1/20 0.39
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
ALDH1A1 P00352 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38
APH1B Q8WW43 1/20 0.38
NCSTN Q92542 1/20 0.38
APH1A Q96BI3 1/20 0.38
PSENEN Q9NZ42 1/20 0.38
LMNA P02545 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
GLA P06280 1/20 0.37
PKM P14618 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL928273 0.91 MAPT (0.49) MAPTRORCALDH1A1LMNASMN1; SMN2
SCHEMBL926737 0.86 LMNA (0.46) MAPTMMP8MMP3RORCPTGER3
SCHEMBL928845 0.86 MAPT (0.45) MAPTRORCLMNASMN1; SMN2TAAR1
SCHEMBL926976 0.85 HSD11B1 (0.46) MAPTRORCPTGER3ALDH1A1PSEN1
SCHEMBL926180 0.85 LMNA (0.48) MAPTMMP8MMP3RORCPTGER3
SCHEMBL926338 0.85 FKBP1A (0.49) ALDH1A1NPSR1PSEN1PSEN2APH1B
SCHEMBL926562 0.85 NPC1 (0.50) MMP8MMP3RORCPTGER3ALDH1A1
SCHEMBL927527 0.84 FKBP1A (0.48) RORCPTGER3ALDH1A1NPSR1PSEN1
SCHEMBL926558 0.84 MAPT (0.54) MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL926406 0.82 FKBP1A (0.47) MMP8MMP3ALDH1A1NPSR1PSEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7872021-B2 LXR receptor modulators LABORATORIES FOURNIER S.A. (FR) 2011-01-18 US disclosed
US-20070099960-A1 LXR receptor modulators LABORATOIRES FOURNIER S.A. (FR) 2007-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099960-A1 LXR receptor modulators NR1H2, NR1H3, PPARD MAPT 1687/4885MMP8 4719/4885MMP3 4694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.